CDC25A and cancer: Altogether, the results of our study indicate that MTA commits RCM‐1 cancer cells toward their differentiation into dome tissue via the down‐regulation and dysfunction of CDC25A and possibly of CCNE2, the key cell‐cycle regulators in the G1 phase.